Citrate-Based Biomaterials for Bone Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current orthopedic biomaterials for bone regeneration lack biochemical and biological coordination, leading to poor incorporation into native bone and prolonged healing times for conditions like nonunion defects, trauma injuries, and metabolic disorders.
Innovation Solution
Development of a citrate-based biodegradable photoluminescent polymer (BPLP-PSer) that incorporates phosphoserine, which promotes osteogenic phenotype through metabonegenic regulation, combined with hydroxyapatite microparticulate scaffolds for enhanced bone regeneration by controlled release of bioactive factors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional orthopedic biomaterials are used for bone regeneration, then the materials are simple to manufacture and use, but they lack biochemical and biological coordination resulting in poor incorporation into native bone and prolonged healing times
Solution Approach 1:
The patent employs composite materials consisting of citrate-based polymer combined with hydroxyapatite microparticulate scaffolds. This composite structure provides both the mechanical support needed for bone regeneration and the biochemical signals (citrate and phosphoserine) that coordinate with native bone biology, thereby improving incorporation quality while maintaining reasonable healing timelines through controlled release mechanisms
Solution Approach 2:
The patent utilizes parameter changes by controlling the temporal release profiles of citrate and phosphoserine from the biomaterial. By adjusting the release kinetics and concentration gradients of these bioactive factors over time, the material dynamically coordinates with different stages of bone healing, improving incorporation quality without excessively prolonging healing time
2Productivity
If complex citrate-based biomaterials with controlled release are used, then bone regeneration is accelerated through metabonegenic regulation, but the device complexity and manufacturing difficulty increase
Solution Approach 1:
The patent merges multiple functions into a single integrated biomaterial system: the citrate-based polymer provides structural support, the incorporated hydroxyapatite microparticulates provide osteoconductive surfaces, and the controlled release of citrate and phosphoserine provides biochemical regulation. This consolidation achieves accelerated bone regeneration through metabonegenic regulation while avoiding the need for multiple separate components that would increase device complexity
Solution Approach 2:
The biomaterial utilizes self-service principles by incorporating hydrolyzable phosphate bonds that automatically release phosphoserine through physiological hydrolysis, and citrate that is released through controlled degradation. This self-regulating release mechanism accelerates bone regeneration through metabonegenic regulation without requiring complex external control systems or active pumping mechanisms
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The citrate-based biomaterials accelerate bone regeneration by promoting an osteogenic phenotype and improving tissue response, leading to faster bone deposition and healing in animal models of cranial and condyle defects.
Implementation Method 1
a novel citrate-based orthopedic biomaterial was designed and implemented in animal models... a brightly photoluminescent polymer that enables a multitude of imaging functionalities
Implementation Method 2
a biodegradable platform... controlled temporal release of bioactive factors, citrate and PSer, from a biodegradable platform
Data Source
AI summary
This invention relates to compositions and methods for promoting and/or accelerating bone regeneration, repair, and/or healing and, in particular, to compositions and methods of promoting bone regeneration, growth, repair, and/or healing using graft or scaffold materials. In exemplary embodiments, the disclosed compositions may be used to promote and/or accelerate bone regeneration by delivering a composition to a bone site, the composition comprising (a) a citrate component, (b) a phosphate component, and, optionally, (c) a particulate inorganic material. The citrate component and/or phosphate component is advantageously released from the composition at the bone site. The released citrate component may function to increase alkaline phosphatase activity and/or expression at the bone site, and the increased alkaline phosphatase activity and/or expression may release the phosphate component. The composition may be delivered in various forms, e.g., as a biodegradable scaffold.